Detailed TOC of Investigation Report on China's Insulin Glargine Market 2021-2025
1 Relevant Concepts of Insulin Glargine1.1 Indications for Insulin Glargine
1.2 Development of Insulin Glargine in China
1.3 Governmental Approval of Insulin Glargine in China
1.4 The Impact of COVID-19 on Insulin Glargine Sales in China
2 Sales of Insulin Glargine in China, 2016-2020
2.1 Sales Value of Insulin Glargine
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Insulin Glargine
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Insulin Glargine by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Analysis of Other Dosage Forms
3 Analysis of Major Insulin Glargine Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Insulin Glargine Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales Volume
3.2 Sanofi-Aventis Deutschland GmbH Germany
3.2.1 Enterprise Profile
3.2.2 Sales of LANTUS &TOUJEO (Sanofi-Aventis Deutschland GmbH Germany’s Insulin Glargine) in China
3.3 Gan&Lee Pharmaceuticals Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of BASALIN (Gan&Lee Pharmaceuticals Co., Ltd.’s Insulin Glargine) in China
3.4 Zhuhai United Laboratories Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of USLEN (Zhuhai United Laboratories Co., Ltd.’s Insulin Glargine) in China
4 Prices of Insulin Glargine for Different Manufacturers in China, 2020-2021
4.1 Sanofi-Aventis Deutschland GmbH Germany (LANTUS &TOUJEO)
4.2 Gan&Lee Pharmaceuticals Co., Ltd. (BASALIN)
4.3 Zhuhai United Laboratories Co., Ltd. (USLEN)
5 Prospect of Chinese Insulin Glargine Market, 2021-2025
5.1 Influential Factors of Chinese Insulin Glargine Market Development
5.1.1 The Impact of COVID-19 on Chinese Insulin Glargine Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Insulin Glargine Injection Registration in China
Chart Sales Value of Insulin Glargine Injection over the World
Chart Sales Value of Insulin Glargine Injection in China, 2016-2020
Chart Sales Value of Insulin Glargine Injection in China by Region, 2016-2020
Chart Sales Volume of Insulin Glargine Injection in China, 2016-2020
Chart Sales Volume of Insulin Glargine Injection in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Insulin Glargine Manufacturers in China, 2016-2020
Chart Sales Value and Volume of LANTUS &TOUJEO in China, 2016-2020
Chart Sales Value and Volume of BASALIN in China, 2016-2020
Chart Sales Value and Volume of USLEN in China, 2016-2020
Chart Referential Prices of LANTUS &TOUJEO in China by Region, 2020-2021
Chart Referential Prices of BASALIN in China by Region, 2020-2021
Chart Referential Prices of USLEN in China by Region, 2020-2021
Chart Forecast on Sales Value of Insulin Glargine in China, 2021-2025
Chart Forecast on Sales Volume of Insulin Glargine in China, 2021-2025
Keyplayers in Investigation Report on China's Insulin Glargine Market 2021-2025
Sanofi-Aventis Deutschland GmbH Germany (LANTUS &TOUJEO)Gan&Lee Pharmaceuticals Co., Ltd. (BASALIN)
Zhuhai United Laboratories Co., Ltd. (USLEN)